| Gaucher disease: pathological mechanisms and modern management M Jmoudiak, AH Futerman British journal of haematology 129 (2), 178-188, 2005 | 319 | 2005 |
| Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience A Zimran, G Altarescu, M Philips, D Attias, M Jmoudiak, M Deeb, N Wang, ... Blood 115 (23), 4651-4656, 2010 | 108 | 2010 |
| Phase I/II and extension study of velaglucerase alfa (Gene-Activated™ human glucocerebrosidase) replacement therapy in adults with type 1 Gaucher disease: 48-month experience A Zimran, G Altarescu, M Phillips, D Attias, M Jmoudiak, M Deeb, N Wang, ... Blood, blood-2010-02-268649, 2010 | 22 | 2010 |
| Iliopsoas hematoma in a young patient with type I Gaucher disease M Jmoudiak, M Itzchaki, I Hadas-Halpern, M Hrebicek, K Hodanova, ... IMAJ-RAMAT GAN- 5 (9), 673-674, 2003 | 8 | 2003 |
| Phase I/II and extension study of velaglucerase alfa (Gene-Activated K Bhirangi, GM Cohn, D Elstein, A Zimran, G Altarescu, M Phillips, ... | | |
| FOR PROOF ONLY A Zimran, G Altarescu, M Philips, D Attias, M Jmoudiak, M Deeb, N Wang, ... | | |
